Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CRON logo CRON
Upturn stock ratingUpturn stock rating
CRON logo

Cronos Group Inc (CRON)

Upturn stock ratingUpturn stock rating
$1.91
Last Close (24-hour delay)
Profit since last BUY-4.5%
upturn advisory
WEAK BUY
BUY since 36 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: CRON (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

5 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Year Target Price $1.95

Year Target Price $1.95

Analyst’s Price TargetsFor last 52 week
$1.95Target price
Low$1.6
Current$1.91
high$2.54

Analysis of Past Performance

Type Stock
Historic Profit -34.08%
Avg. Invested days 27
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 734.41M USD
Price to earnings Ratio 13.57
1Y Target Price 1.95
Price to earnings Ratio 13.57
1Y Target Price 1.95
Volume (30-day avg) 5
Beta 1.52
52 Weeks Range 1.60 - 2.54
Updated Date 06/29/2025
52 Weeks Range 1.60 - 2.54
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.14

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 39.69%
Operating Margin (TTM) -10.9%

Management Effectiveness

Return on Assets (TTM) -2.42%
Return on Equity (TTM) 4.59%

Valuation

Trailing PE 13.57
Forward PE -
Enterprise Value -101590757
Price to Sales(TTM) 5.89
Enterprise Value -101590757
Price to Sales(TTM) 5.89
Enterprise Value to Revenue 0.02
Enterprise Value to EBITDA -1.42
Shares Outstanding 385419008
Shares Floating 204815522
Shares Outstanding 385419008
Shares Floating 204815522
Percent Insiders 46.73
Percent Institutions 14.32

Analyst Ratings

Rating 3
Target Price 1.95
Buy 1
Strong Buy 1
Buy 1
Strong Buy 1
Hold 2
Sell 1
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Cronos Group Inc

stock logo

Company Overview

overview logo History and Background

Cronos Group Inc. was founded in 2012 and is headquartered in Toronto, Canada. It's a global cannabinoid company committed to improving lives through cannabis. It has undergone significant expansion and strategic partnerships since its inception.

business area logo Core Business Areas

  • Dried Cannabis: Production and distribution of dried cannabis flowers for recreational and medical use.
  • Oils and Concentrates: Production and distribution of cannabis oils and concentrates for various applications, including vaping and edibles.
  • Edibles: Production and distribution of cannabis-infused edibles, such as gummies and chocolates.
  • Vaporizers: Sales of vaporizers for cannabis consumption.
  • Strategic Partnership: Strategic partnership with Ginkgo Bioworks to produce cultured cannabinoids at scale.

leadership logo Leadership and Structure

Cronos Group Inc's leadership team includes key executives in areas such as CEO, CFO, and Chief Legal Officer. The organizational structure is typical of a publicly traded company, with various departments responsible for research, production, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • Spinach: Spinach is one of Cronos' key brands in the Canadian recreational market. Market share data varies but they are considered to be in top 3-5 brands. Competitors include Canopy Growth (CGC), Tilray (TLRY).
  • Peace Naturals: Peace Naturals is a brand focused on medical cannabis. Market data is limited, but they aim to provide consistent, high-quality medical cannabis. Competitors are similar to Spinach, with added focus on medical brands such as Aurora Cannabis (ACB).
  • Lord Jones: Lord Jones is a luxury CBD brand in the US. Market share in this sector is competitive. Competitors include Charlotte's Web (CWBHF).

Market Dynamics

industry overview logo Industry Overview

The cannabis industry is experiencing growth but also faces regulatory hurdles and intense competition. It involves the cultivation, processing, distribution, and retail of cannabis products for both medical and recreational use.

Positioning

Cronos Group Inc. is positioned as a global cannabinoid company with a focus on branded products and innovative research. The company is competing with other big market cap cannabis companies for market share.

Total Addressable Market (TAM)

The global cannabis market is projected to reach hundreds of billions in the coming years. Cronos Group Inc. aims to capture a significant share through brand building and innovative products.

Upturn SWOT Analysis

Strengths

  • Strong Brand Portfolio
  • Partnership with Altria Group (MO)
  • Focus on Innovation
  • Global Presence

Weaknesses

  • Limited Profitability
  • High Operating Expenses
  • Dependence on Regulatory Changes
  • Market Volatility

Opportunities

  • Expansion into New Markets
  • Development of New Products
  • Increased Legalization
  • Growing Consumer Acceptance

Threats

  • Intense Competition
  • Regulatory Uncertainty
  • Price Volatility
  • Changing Consumer Preferences

Competitors and Market Share

competitor logo Key Competitors

  • TLRY
  • CGC
  • ACB
  • CWBHF

Competitive Landscape

Cronos Group Inc. competes in a highly competitive market. The companyu2019s advantages include a strong brand portfolio and partnership with Altria. Disadvantages include limited profitability and market volatility.

Major Acquisitions

Lord Jones

  • Year: 2019
  • Acquisition Price (USD millions): 300
  • Strategic Rationale: Expansion into the U.S. CBD market with a luxury brand.

Growth Trajectory and Initiatives

Historical Growth: Cronos Group Inc. has demonstrated revenue growth in past years, driven by increasing sales and market expansion. However, the company still struggles with profitability.

Future Projections: Future growth depends on further legalization and market penetration. Analyst estimates vary widely depending on changing regulatory conditions.

Recent Initiatives: Recent initiatives include product innovation, market expansion, and partnerships to scale production and distribution.

Summary

Cronos Group Inc. is navigating a challenging and evolving cannabis industry. Its partnership with Altria provides financial stability and market access. However, the company needs to improve profitability and navigate regulatory uncertainties. Cronos shows promise in innovating and establishing a strong market presence but its success hinges on how well the company handles its weaknesses and external threats.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC)
  • Market Research Reports
  • Analyst Estimates

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company-specific events may impact the accuracy of the data.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Cronos Group Inc

Exchange NASDAQ
Headquaters Stayner, ON, Canada
IPO Launch date 2016-07-12
President, CEO & Chairman Mr. Michael Ryan Gorenstein J.D.
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 459
Full time employees 459

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.